{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:50:38Z","timestamp":1789876238580,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.japh.2022.10.028","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T03:19:12Z","timestamp":1667359152000},"page":"566-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["An observational study of the extent of naloxone furnishing in California Central Valley community pharmacies"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-1234","authenticated-orcid":false,"given":"Micah","family":"Banawis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0678-3029","authenticated-orcid":false,"given":"Gordon","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-7763","authenticated-orcid":false,"given":"Rania","family":"Mohsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1902-0127","authenticated-orcid":false,"given":"Jethro","family":"Pobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-701X","authenticated-orcid":false,"given":"Darrin","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1874-3326","authenticated-orcid":false,"given":"Anna V.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-0826","authenticated-orcid":false,"given":"Dorie E.","family":"Apollonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2022.10.028_bib1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1353\/hpu.2007.0062","article-title":"Health professional shortage and health status and health care access","volume":"18","author":"Liu","year":"2007","journal-title":"J\u00a0Health Care Poor Underserved"},{"issue":"6","key":"10.1016\/j.japh.2022.10.028_bib2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jep.13360","article-title":"Can primary care access reduce health care utilization for patients with obesity-associated chronic conditions in medically underserved areas?","volume":"26","author":"Dashputre","year":"2020","journal-title":"J\u00a0Eval Clin Prac"},{"issue":"6","key":"10.1016\/j.japh.2022.10.028_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archfami.8.6.487","article-title":"preventable hospitalizations in primary care shortage areas: an analysis of vulnerable medicare beneficiaries","volume":"8","author":"Parchman","year":"1999","journal-title":"Arch Fam Med"},{"issue":"5","key":"10.1016\/j.japh.2022.10.028_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCOUTCOMES.111.960922","article-title":"Association of health professional shortage areas and cardiovascular risk factor prevalence, awareness, and control in the multi-ethnic study of atherosclerosis (MESA).","volume":"4","author":"Allen","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.japh.2022.10.028_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.japh.2020.08.032","article-title":"Evaluation of naloxone furnishing community pharmacies in San Francisco","volume":"60","author":"Nguyen","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2022.10.028_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1176\/appi.ps.691004","article-title":"Addressing the opioid epidemic in rural America","volume":"69","author":"Flaherty","year":"2018","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.japh.2022.10.028_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/pharmacy8040205","article-title":"Pharmacy students' perceptions and stigma surrounding naloxone use in patients with opioid use disorder: a mixed methods evaluation","volume":"8","author":"Cernasev","year":"2020","journal-title":"Pharmacy"},{"issue":"1","key":"10.1016\/j.japh.2022.10.028_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.japh.2021.09.010","article-title":"The impact of community pharmacy utilization of immunization information systems on vaccination rates: results of a clustered randomized controlled trial","volume":"62","author":"Heaton","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"4","key":"10.1016\/j.japh.2022.10.028_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40615-019-00570-3","article-title":"Contraceptive desert? Black-White differences in characteristics of nearby pharmacies","volume":"6","author":"Barber","year":"2019","journal-title":"J\u00a0Racial Ethnic Health Disparities"},{"issue":"11","key":"10.1016\/j.japh.2022.10.028_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ajhp\/60.11.1123","article-title":"Improving primary care in rural alabama with a pharmacy initiative","volume":"60","author":"Taylor","year":"2003","journal-title":"Am J Health Pharm"},{"key":"10.1016\/j.japh.2022.10.028_bib14","unstructured":"2022 Lawbook for Pharmacy \u00a7 1746.5. Protocol for pharmacists furnishing naloxone Hydrochloride. Cal. Bus. & Prof. Code \u00a7 4052.01. Available at: https:\/\/www.pharmacy.ca.gov\/laws_regs\/pharmacy_lawbook.shtml. Accessed December 1, 2022."},{"key":"10.1016\/j.japh.2022.10.028_bib15","unstructured":"2022 Lawbook for Pharmacy \u00a7 4052.8. Cal. Bus & Prof Code \u00a7 4052.8. Initiation and Administration of Vaccines. Available at: https:\/\/www.pharmacy.ca.gov\/laws_regs\/pharmacy_lawbook.shtml. Accessed December 1, 2022."},{"key":"10.1016\/j.japh.2022.10.028_bib16","unstructured":"2022 Lawbook for Pharmacy \u00a7 4052.3 Emergency Contraception Drug Therapy. Available at: https:\/\/www.pharmacy.ca.gov\/laws_regs\/pharmacy_lawbook.shtml. Accessed December 1, 2022."},{"issue":"5","key":"10.1016\/j.japh.2022.10.028_bib19","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.japh.2021.06.020","article-title":"Pharmacist furnishing of naloxone in California: a follow-up analysis","volume":"61","author":"Puzantian","year":"2021","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"18","key":"10.1016\/j.japh.2022.10.028_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1001\/jama.2018.12291","article-title":"Provision of naloxone without a prescription by California pharmacists 2 years after legislation implementation","volume":"320","author":"Puzantian","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.japh.2022.10.028_bib21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.japh.2020.07.019","article-title":"Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies","volume":"60","author":"Chen","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2022.10.028_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.japh.2021.08.001","article-title":"An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay area pharmacies","volume":"62","author":"Bellman","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2022.10.028_bib23","author":"Esqueda"},{"key":"10.1016\/j.japh.2022.10.028_bib25","author":"Hedegaard"},{"key":"10.1016\/j.japh.2022.10.028_bib28","article-title":"Grounded theory research: a design framework for novice researchers","volume":"7","author":"Chun","year":"2019","journal-title":"SAGE Open Med"},{"issue":"8","key":"10.1016\/j.japh.2022.10.028_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.2663","article-title":"Trends in out-of-pocket costs for naloxone by drug brand and payer in the US, 2010-2018","volume":"3","author":"Peet","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"5","key":"10.1016\/j.japh.2022.10.028_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.japh.2020.01.030","article-title":"Evaluation of naloxone access, pricing, and barriers to dispensing in tennessee retail community pharmacies","volume":"60","author":"Spivey","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2022.10.028_bib33","article-title":"Stigma by association: to what extent is the attitude toward naloxone affected by the stigma of opioid use disorder?","author":"Adeosun","year":"2022","journal-title":"J\u00a0Pharm Prac"},{"issue":"5","key":"10.1016\/j.japh.2022.10.028_bib34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/10826084.2019.1703750","article-title":"Opioid addiction stigma: the intersection of race, social class, and gender","volume":"55","author":"Wood","year":"2020","journal-title":"Subst Use Misuse"},{"issue":"2","key":"10.1016\/j.japh.2022.10.028_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1363459320925863","article-title":"Addiction stigma and the production of impediments to take-home naloxone uptake","volume":"26","author":"Fomiatti","year":"2022","journal-title":"Health"},{"issue":"2S","key":"10.1016\/j.japh.2022.10.028_bib36","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.japh.2017.01.013","article-title":"Perpetuating stigma or reducing risk? perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states","volume":"57","author":"Green","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:17Z","timestamp":1761544337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122003764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1544319122003764"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.10.028","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An observational study of the extent of naloxone furnishing in California Central Valley community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}